MedPath

Pole Walking Intervention in Retirement Communities

Not Applicable
Recruiting
Conditions
Fall Injury
Osteoporotic Fractures
Registration Number
NCT05388227
Lead Sponsor
University of Saskatchewan
Brief Summary

This patient-oriented, multi-site study aims to co-design and test a pole walking program with resident and staff representatives from participating independent living and retirement communities.

The first part of the study (feasibility phase) is a single-group trial designed to answer the main question: Is the pole walking program feasible in these settings? In this phase, all participants will take part in the program.

The second part of the study (pilot phase) is a two-group randomized trial that will assess whether the program helps improve physical activity, physical function, body composition, fear of falling, and health-related quality of life, while also reducing sedentary time (time spent sitting or being inactive) in older adults living in independent living and retirement communities. Communities will be randomly assigned to either start the program right away or join a wait-list control group.

The program will include supervised group sessions held at the participating communities, 2-3 times per week, for 20-60 minutes each session, over a 12-week period. Sessions will take place outdoors when possible, or indoors if the weather is not suitable.

After follow-up assessments are complete, participants in the control group will also be offered the pole walking program at their communities.

Detailed Description

Pole walking provides an attractive form of exercise therapy for older adults. It is a simple, well-tolerated, and effective means to improve overall functional fitness in older adults. Pole walking has improved upper and lower body muscle strength, cardiovascular endurance, and flexibility in community-dwelling older adults. It has been positively associated with balance, functional mobility, muscle strength, and aerobic exercise capacity in older adults. Pole walking is considered to offer a safe format for walking, as poles provide support and help with balance, and thus contribute to confidence in being active. However, there has not yet been a study assessing the feasibility and efficacy of a pole walking intervention in improving physical activity, physical function, body composition, fear of falling, and health-related quality of life, and decreasing sedentary time in older adults living in independent living/retirement communities.

This patient-oriented, multi-site study consists of a feasibility and a pilot phase. The feasibility phase is a single-arm trial that will assess the feasibility and safety of implementing a pole walking intervention within independent living/retirement communities. In this phase, all participants will receive the intervention. The pilot phase is a two-arm, parallel-group, cluster-randomized, wait-list controlled trial that will assess the efficacy of the pole walking intervention in improving physical activity, physical function, body composition, fear of falling, and health-related quality of life, and decreasing sedentary time in older adults living in independent living/retirement communities. In this phase, our target is to include 50 residents from independent living/retirement communities. Sites will be randomized to either the intervention or a wait-list control group. The intervention will consist of group sessions held at the participating communities, 2-3 times per week, for 20-60 minutes per session, over a 12-week period. Pole walking exercises are tailored for participants and progressive in nature. Sessions will be led by trained peer, staff, or student instructors and conducted outdoors (indoors if weather conditions do not permit). After completing follow-up assessments, participants in the control group will also be offered the pole walking program at their sites.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Being an ambulatory resident in the independent living/retirement communities.
  • Pass the Get Active Questionnaire. If the participant has heart conditions, angina during daily living, balance, and bone or joint problems, then a Physician Clearance Form is required to be filled out and signed by the participant's family physician.
Exclusion Criteria
  • Using assistive devices for mobility.
  • Being active (moderate-to-vigorous physical activity ≥150 min/week).
  • Diagnosed with Parkinson's disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Feasibility of pole walking intervention - consent rateAfter the completion of the study's feasibility phase (1 year)

Assessed by calculating consent rate (%) as the percentage of participants assessed for eligibility who consented.

Feasibility of pole walking intervention - recruitment rateAfter the completion of the study's feasibility phase (1 year)

Assessed by calculating recruitment rate (participant/site/month) as the number of potentially eligible participants who consented divided by the number of recruiting sites and then divided by the number of months spent on recruitment.

Feasibility of pole walking intervention - retention rateAfter the completion of the study's feasibility phase (1 year)

Assessed by calculating retention rate (%) as the percentage of eligible participants enrolled in the study who received the allocated intervention and completed both baseline and follow-up assessments.

Feasibility of pole walking intervention - attendance rateAfter the completion of the study's feasibility phase (1 year)

Assessed by calculating attendance rate (%) as the percentage of available intervention sessions attended by each participant.

Feasibility of pole walking intervention - intervention acceptability scoreFollow-up assessment sessions (after the 12-week intervention of the study's feasibility phase)

Assessed by calculating intervention acceptability score (ranging from 1-5, with higher scores indicating greater acceptability of an intervention ) using the 4-item intervention acceptability measure.

Feasibility of pole walking intervention - intervention appropriateness scoreFollow-up assessment sessions (after the 12-week intervention of the study's feasibility phase)

Assessed by calculating intervention appropriateness score (ranging from 1-5, with higher scores indicating greater appropriateness of an intervention ) using the 4-item intervention appropriateness measure.

Feasibility of pole walking intervention - intervention feasibility scoreFollow-up assessment sessions (after the 12-week intervention of the study's feasibility phase)

Assessed by calculating intervention feasibility score (ranging from 1-5, with higher scores indicating greater feasibility of an intervention ) using the 4-item intervention feasibility measure.

Physical function - functional balance/mobilityBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by the timed "up \& go" test.

Physical function - lower-body strengthBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by the 30-s chair stand test.

Health-related quality of lifeBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by the 36-item short form survey, which provides a score ranging from 0-100 for each of its 8 scales (the higher the scale scores, the more favorable the corresponding health states).

Secondary Outcome Measures
NameTimeMethod
Safety of pole walking interventionFollow-up assessment sessions (after the 12-week intervention of the study's feasibility phase)

Assessed by the seriousness and relatedness to the intervention of recorded adverse events.

Physical function - functional capacityBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by the 6-min walk test.

Physical function - upper-body strengthBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by the grip strength test.

Physical activity/sedentary timeBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by 7-day accelerometry.

Fear of fallingBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by the 10-item falls efficacy scale, which provides a total score ranging from 10-100, with higher scores suggesting greater fear of falling.

Body composition - musculoskeletal properties of the lower legBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by the peripheral quantitative computed tomography.

Body composition - musculoskeletal properties of the forearmBaseline and follow-up assessment sessions (before and after the 12-week intervention of the study's feasibility and pilot phases)

Assessed by the peripheral quantitative computed tomography.

Trial Locations

Locations (1)

Saija Kontulainen, University of Saskatchewan

🇨🇦

Saskatoon, Saskatchewan, Canada

Saija Kontulainen, University of Saskatchewan
🇨🇦Saskatoon, Saskatchewan, Canada
Saija Kontulainen, PhD
Contact
(306) 966-1077
saija.kontulainen@usask.ca
Mohsen Keramati, MSc
Contact
(306) 371-4823
mohsen.keramati@usask.ca

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.